Lead Product(s): VHH72-Fc antibody
Therapeutic Area: Infections and Infectious Diseases Product Name: XVR011
Highest Development Status: IND Enabling Product Type: Large molecule
Deal Size: $50.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing March 16, 2021
Unique llama-derived VHH72-Fc antibody (XVR011) for potential treatment and prevention of Covid-19, ready to start first-in-human trials.